mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |